TARCOCIMAB
UNII QNU3MX7NBY

Substance Identification & Data

This profile provides standardized clinical and technical data for Tarcocimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QNU3MX7NBY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408661-40-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QNU3MX7NBY

CAS Registry Number

2408661-40-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TARCOCIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184872

National Cancer Institute reference terminology for clinical and research data.

INN ID

11770

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-250

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tarcocimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TARCOCIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE,243-ALANINE,449-CYSTEINE), ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL OG1950 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OG1950 .KAPPA.-CHAIN,(232->232'),(235->235')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL OG1950 .GAMMA.1-CHAIN)DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OG1950 .KAPPA.-CHAIN

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV3- 30*02 (75.8%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT (8.8.16) (26- 33.51-58.97-112)) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1, G1V14 CH2 A1.3, A1.2 (CH1 R120>K (220) (124-221), HINGE 1-15 (222-236), CH2 L13.>A (240), L1.2>A (241), G1>A (243) (237- 346), CH3 E12 (362), M14 (364), L123>C (449) (347-451), CHS (452- 453)) (124-453)), (226-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (87.4%) -IGKJ1*01 (100%), CDR-IMGT (6.3.9) (27- 32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GS-KO), GLYCOFORM ALFA

TARCOCIMAB [INN]

TARCOCIMAB [USAN]